2,521
Views
13
CrossRef citations to date
0
Altmetric
Original Research

The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction

, , , , , , & show all

References

  • FergusonGT. Why does the lung hyperinflate? Proc Am Thorac Soc. 2006; 3(2):176–179.
  • O'Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3(2):180–184.
  • Tzani P, Aiello M, Elia D, Boracchia L, MarangioE, Olivieri D, Clini E, Chetta A. Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients. Respir Res 2011; 12(1):150.
  • ZafarMA, Tsuang W, Lach L, Eschenbacher W, Panos RJ. Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease. Lung 2013; 191(2):177–182.
  • Coxson HO. Quantitative chest tomography in COPD research: chairman's summary. Proc Am Thorac Soc 2008; 5(9): 874–877.
  • StolkJ, VersteeghMIM, Montenij LJ, Bakker ME, GrebskiE, TuticM, Wildermuth S, WederW, el BardijiM, Reiber JH, RabeKF, Russi EW, StoelBC. Densitometry for assessment of effect of lung volume reduction surgery for emphysema. Eur Respir J 2007; 29(6):1138–1143.
  • Gould GA, Redpath AT, RyanM, Warren PM, BestJJ, FlenleyDC, MacNee W. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991; 4(2):141–146.
  • Müller NL, StaplesCA, Miller RR, AbboudRT. “Density mask”. An objective method to quantitate emphysema using computed tomography. Chest 1988; 94(4):782–787.
  • Mair G, Miller JJ, McAllisterD, MaclayJ, Connell M, MurchisonJ T, MacNee W. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J 2009; 33(3):536–542.
  • McNulty W, Zoumot Z, Hopkinson NS. Bronchoscopic and percutaneous approaches to lung volume reduction. Clin Pulm Med 2013; 20(6):300–308.
  • Murphy PB, Zoumot Z, Polkey MI. Noninvasive ventilation and lung volume reduction. Clin Chest Med 2014; 35(1):251–269.
  • Sanchez PG, KucharczukJC, SuS, Kaiser LR, CooperJD. National Emphysema Treatment Trial redux: accentuating the positive. J Thorac Cardiovasc Surg 2010; 140(3):564–572.
  • McKenna RJ Jr, BrennerM, FischelRJ, SinghN, YoongB, Gelb AF, Osann KE. Patient selection criteria for lung volume reduction surgery. J Thorac Cardiovasc Surg 1997; 114(6):957–964; discussion 964–967.
  • De TorresJP, Bastarrika G, ZagacetaJ, Sáiz-MendigurenR, Alcaide AB, SeijoLM, CampoA, ZuluettaJJ. Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD. Chest 2011; 139(1):36–42.
  • ClarkSJ, ZoumotZ, BamseyO, PolkeyMI, Dusmet M, LimE, JordnS, HopkinsonNS. Surgical approaches for lung volume reduction in emphysema. Clin Med Lond 2014; 14(2):122–127.
  • ShahPL, ZoumotZ, Singh S, Bicknell SR, Ross ET, QuiringJ, HopkinsonNS, Kemp SV; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013; 1(3):233–240.
  • DaveyC, ZoumotZ, JordanS, Carr DH, PolkeyMI, Shah PL, Hopkinson NS. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (The BeLieVeR-HIFi trial): study design and rationale. Thorax 2014 Mar 24; doi: 10.1136/thoraxjnl-2014-205127. [Epub ahead of print]
  • ZoumotZ, KempSV, CanejaC, SinghS, ShahPL. Bronchoscopic intrabullous autologous blood instillation: a novel approach for the treatment of giant bullae. Ann Thorac Surg 2013; 96(4):1488–1491.
  • Zavorsky GS, Cao J, Mayo NE, Gabbay R, Murias JM. Arterial versus capillary blood gases: a meta-analysis. Respir Physiol Neurobiol 2007; 155(3):268–279.
  • Quanjer PH, Tammeling GJ, Cotes JE, PedersenOF, PeslinR, YernaultJC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5–40.
  • Clark EH, WoodsRL, Hughes JM. Effect of blood transfusion on the carbon monoxide transfer factor of the lung in man. Clin Sci Mol Med 1978; 54(6):627–631.
  • GieradaDS, YusenRD, Pilgram TK, Crouch L, SloneRM, BaeKT, Lefrak SS, Cooper JD. Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery. Radiology 2001; 220(2):448–454.
  • Gevenois PA, de MaertelaerV, De VuystP, ZanenJ, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152(2):653–657.
  • Gietema HA, Müller NL, Fauerbach PVN, Sharma S, Edwards LD, Camp PG, et al. Quantifying the extent of emphysema: factors associated with radiologists’ estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol 2011; 18(6):661–671.
  • WangZ, Gu S, LeaderJK, KunduS, Tedrow JR, SciurbaFC, GurD, Siegfried JM, Pu J. Optimal threshold in CT quantification of emphysema. Eur Radiol 2013; 23(4):975–984.
  • GieradaDS, Slone RM, Bae KT, Yusen RD, Lefrak SS, CooperJD. Pulmonary emphysema: comparison of preoperative quantitative CT and physiologic index values with clinical outcome after lung-volume reduction surgery. Radiology 1997; 205(1):235–242.
  • National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 2001; 345(15):1075–1083.
  • American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167(2):211–277.
  • WassermanK. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. Lippincott Williams & Wilkins, Philadelphia, PA; 2005. 620 p.
  • Beaver WL, Wasserman K, WhippBJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60(6):2020–2027.
  • GuenetteJA, Chin RC, CoryJM, Webb KA, O'Donnell DE. Inspiratory Capacity during exercise: measurement, analysis, and interpretation. Pulm Med 2013; 2013:956081
  • Russi EW, Bloch KE, Weder W. Functional and morphological heterogeneity of emphysema and its implication for selection of patients for lung volume reduction surgery. Eur Respir J 1999; 14(1):230–236.
  • Weder W, ThurnheerR, Stammberger U, BürgeM, RussiEW, Bloch KE. Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. Ann Thorac Surg 1997; 64(2):313–319
  • Hopkinson NS, KempSV, Toma TP, Hansell DM, Geddes DM, ShahPL, Polkey MI. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J 2011; 37(6):1346–1351.
  • Puente-Maestu L, Stringer WW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1(4):381–400.
  • GagnonP, Guenette JA, Langer D, Laviolette L, MainguyV, MaltaisF, Ribeiro F, SaeiD. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014; 9:187–201.
  • O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006; 3(4):219–232.
  • MaltaisF, HamiltonA, MarciniukD, HernandezP, SciurbaFC, Richter K, KestenS, O'DonnellD. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005; 128(3):1168–1178.
  • HopkinsonNS, Toma TP, Hansell DM, GoldstrawP, MoxhamJ, GeddesDM, PolkeyMI. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171(5):453–460.
  • O'Donnell DE, Lam M, WebbKA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(5 Pt 1):1557–1565.
  • Vassaux C, Torre-Bouscoulet L, ZeineldineS, Cortopassi F, Paz-Díaz H, CelliBR, Pinto-Plata VM. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008; 32(5):1275–1282.
  • MillerJD, PegelowDF, Jacques AJ, Dempsey JA. Effects of augmented respiratory muscle pressure production on locomotor limb venous return during calf contraction exercise. J Appl Physiol 2005; 99(5):1802–1815.
  • Montes de Oca M, RassuloJ, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154(5):1284–1289.